Denver-based private equity firm Revelstoke Capital Partners has completed the sale of Accelecare Wound Centers to Healogics.
Accelecare provides advanced wound care services in two diversified, highly complementary divisions, Accelecare Wound Centers, which offers full service wound management solutions to hospitals and related healthcare organisations, and Accelecare Wound Professionals, which provides wound care specialist physicians to skilled nursing facilities and hospital-based outpatient wound care facilities.
“We are very pleased with the pace of Accelecare’s growth since we completed our investment in December 2013. Management’s intense focus on expanding the Company’s footprint while increasing operational efficiencies created an attractive asset in the growing wound care market,” says Mark King, CEO, Managing Partner and Co-Founder of Revelstoke.
“We appreciate Revelstoke’s strategic guidance and support in our rapid growth, and we look forward to a great future with Healogics,” says Michael Lester, Chairman and CEO of Accelecare.
“Accelecare has an exceptional market position and brand reputation in the wound care industry. We see incredible value in this acquisition, through which the combined business will benefit from increased operational scale enabling us to reach and heal more patients with chronic wounds,” says Jeff Nelson, CEO of Healogics.
